ROMEGA is a high-end nutrition brand of Norwegian listed pharmaceutical company Arctic Bioscience (stock code: ABS). Our headquarters is located in Osta, on the west coast of Norway（Ørsta）. The ROMEGA core team formed by scientists and clinical experts has more than 30 years of rich experience in marine biology, clinical nutrition and pharmaceutical research and development. We pursue cutting-edge scientific research and technological innovation. After more than 10 years of technological development and clinical research, we have published more than 20 academic papers and obtained many invention patents.
Arctic Bioscience Adhering to the principle of sustainable development and the concept of continuous innovation, based on polar marine living resources, we are committed to the development and utilization of marine biological active substances, and provide high-quality products and solutions to meet the nutritional needs of human life at all stages.
In 1990, Dr. Hogne started the research on herring seeds, and found that the phospholipids in herring seeds have unique biological activity, which can promote the nerve development of fish and mammals.
In 2000, Dr. Hogne and key team members began the separation and purification of phospholipid Omega-3 from herring seeds.
In 2010, the herring seed processing technology and quality control system were optimized to ensure the freshness of raw materials and the safety of products.
In 2011, ROMEGA was officially established, headquartered in Osta, on the west coast of Norway, with a highly educated Arctic nutrition research and development team from Europe and the United States.
In 2016, the first ROMEGA fish seed oil product was launched, and the innovative product rich in phospholipid Omega-3 became the choice of Norwegian citizens.
In 2019, it won the European Small and Medium-sized Enterprise Star Research and Development Award, and won a special fund to expand the research, development and application of ROMEGA products in the medical field.
In 2020, ROMEGA officially entered the Chinese market to provide better products and solutions for Chinese consumers.
In 2021, on February 24, 2021, Arctic Bioscience AS was listed on the European Stock Exchange under the stock code of ABS.